Loading provider…
Loading provider…
Gastroenterology Physician in Beverly Hills, CA
NPI: 1083915763Primary Employer
Cedars-Sinai Medical Care Foundation
cedars-sinai.org
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2011 - 2025
CA State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Gastroenterology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Gastroenterology
2013 - 2016
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 110 | 112 |
| 2 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 84 | 84 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 75 | 85 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 65 | 65 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 59 | 68 |
Novel approaches to treating Clostridium difficile-associated colitis.
Authors: Padua, David, Pothoulakis, Charalabos
Journal: Expert Rev Gastroenterol Hepatol
Publication Date: 2015-12-07
Authors: Rankin, Carl Robert, Lokhandwala, Zulfiqar Ali, Huang, Raymond, Pekow, Joel, Pothoulakis, Charalabos, Padua, David
Journal: Life Sci
Publication Date: 2019-06-14
Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature.
Authors: Nicholas Villano, Samuel Jackson
Publication Date: 2016-08-31
Lead Sponsor: Shire
Intervention / Treatment: OTHER: Placebo, DRUG: Ontamalimab